Navigation Links
Relief "In Sight" for Allergy Sufferers
Date:3/21/2008

n Care, Inc. is offering a free trial-pair certificate(*) for 1-DAY ACUVUE(R) MOIST Brand Contact Lenses.

"When worn on a daily disposable basis, 1-DAY ACUVUE MOIST may provide improved comfort for two out of three patients suffering from mild discomfort associated with allergies during contact lens wear compared to their usual two-week lens," says Dr. Adams.

To receive a free trial-pair certificate(*), visit http://www.acuvue.com where, you also can "Click-to-be-Contacted," through a new online service that offers a quick, easy way to schedule an eye exam for contact lenses with an eye care doctor in your area.

About 1-DAY ACUVUE(R) MOIST.

1-DAY ACUVUE(R) MOIST(TM) is the healthiest, most convenient way to wear contact lenses. These soft contacts offer exceptional all-day comfort and eliminate the need for cleaning, disinfecting solutions, and storage.

1-DAY ACUVUE MOIST employs breakthrough LACREON(TM) technology, a unique process that permanently embeds a water holding ingredient, similar to that found in natural tears, into the proven etafilcon A material of the 1-DAY ACUVUE(R) Brand. This technological advancement locks in moisture that lasts throughout the day, offering relief for the most frequently reported complaints of contact lens discomfort -- dryness and end of day comfort. The new daily disposable lenses also eliminate the need for cleaning, disinfecting solutions, and storage, and compared to two-week lenses, may provide improved comfort for patients who experience mild discomfort and itching associated with allergies during contact lens wear.

1-DAY ACUVUE MOIST is available by prescription only for vision correction. An eye care professional will determine whether contact lenses are right for individual patients. Although rare, serious eye problems can develop. To help avoid these problems, patients should follow the wear and replacement schedule and the lens-
'/>"/>

SOURCE VISTAKON, Division of Johnson & Johnson Vision Care, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Hands on Disaster Response Extends Cyclone Relief Project
2. Pain Relief for Osteoporosis Patients With Fractures
3. Long-Term Data for 884 Patients Show Vertebroplasty for Osteoporotic Spinal Fractures Provides Dramatic Pain Relief, Greatly Decreases Disability
4. ALFA Aims to Provide Relief to Seniors
5. Dementia diagnosis brings relief, not depression
6. Catholic Bishops Welcome New Bill for Global HIV/AIDS Relief
7. Beyond Vanity: New Treatment Brings Relief to Women After Years of Silent Suffering
8. Pain Relief Network Sues to Halt Government Actions Taken Against Kansas Patients
9. Back Pain Spending Up, Relief Down
10. AT&T Tennessee Supports Local Disaster Relief Efforts
11. Idaho Potato Commission Launches Recipes for Relief in Celebration of the International Year of the Potato
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... terminology, and the relevance of palliation in advanced ... randomized controlled trials (RCTs). This is the result ... Quality and Efficiency in Health Care (IQWiG), which ... Together with external experts, IQWiG analysed studies on ... malignant melanoma, and pancreatic cancer. For this purpose, ...
(Date:4/24/2014)... awarded one of 30 grants from the National Cancer ... Site in its new National Clinical Trials Network ... of investigators charged with distributing resources in a more ... system reflects recommendations from a 2010 Institute of ... goals:, Faster design, launch, and completion of ...
(Date:4/23/2014)... by Massachusetts General Hospital (MGH) investigators may lead to ... a serious medical problem use of fecal material ... the Clostridium difficile ( C. difficile ) ... the journal Clinical Infectious Diseases , the researchers ... donors unrelated to patients was as successful in curing ...
(Date:4/23/2014)... J. O,Shea, M.D., scientific director at the National Institute ... been named the 2014 recipient of the Ross Prize ... open-access journal Molecular Medicine . The award will ... Academy of Sciences in Manhattan, followed by scientific presentations ... part of the National Institutes of Health. , The ...
(Date:4/23/2014)... researchers have identified an important enzyme pathway that helps ... few chromosomes, a condition that has been directly linked ... professor of biochemistry, found that near the end of ... that ensures any breaks in DNA are fully repaired ... to daughter cells. This process helps safeguard against some ...
Breaking Medicine News(10 mins):Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3Health News:Dartmouth awarded lead role in NCI clinical trials network 2Health News:Dartmouth awarded lead role in NCI clinical trials network 3Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 3Health News:NIH scientist to receive Ross Prize in Molecular Medicine 2Health News:Study identifies enzymes that help fix cancer-causing DNA defects 2
... of herbal products and medicines has the potential to reach ... the creation of exclusive export promotion zones (EPZ) across ... can be accelerated with the setting up of EPZs in ... rate of over 25 percent in countries like the US, ...
... as marijuana or ganja, can help in the treatment ... body tissues are attacked by its own immune system. ... University of Bonn, used tetrahydrocannabinol (THC), the active ingredient ... that it reduced skin allergies. ,However, the ...
... Today at the 61st Annual Meeting of the ... Cordis Corporation, announced the worldwide launch of the ... use in angioplasty procedures for patients with carotid ... a unique high-pressure expansion and low profile .014 ...
... better way to say "I love you" than showing your Dad ... come . This Father's Day, the American Diabetes Association (ADA) wants ... out by their doctor. ,More than 10 percent of all ... 2 diabetes, the most common form of the disease, can come ...
... number of suicide attempts among asylum seekers in Denmark has ... of despair," according to a study published Thursday . ... camps -- or 0.6 percent of the total -- tried ... by the Danish Association to Help Refugees said. ...
... for a new study has found that regular practice ... as well as the cognitive decline associated with ... practice, is centred on attentional and postural self-regulation and ... normal age-related decline of cerebral gray matter volume and ...
Cached Medicine News:Health News:Export of Herbal Products to Reach Rs.120 Billion by 2012: Study 2Health News:New Balloon Catheter Available Worldwide for Carotid and Renal Angioplasty 2Health News:Drag Dad to the Doctor This Father's Day 2
(Date:1/15/2014)... Most osteoporosis patients want a choice in the medication ... by Mission Pharmacal Company. The survey, conducted by ... community, revealed that 74 percent of osteoporosis patients surveyed ... other than a pill or a tablet. ...
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading health ... several new IT value-added reseller (VAR) national contracts that ... goods and services at lower costs. These include manufacturer ... such as initiative assistance and ongoing IT consulting support. ...
(Date:1/15/2014)...  Humberto C. Antunes,  Galderma  worldwide CEO, will receive a ... of Drugs in Dermatology (JDD) at the upcoming ... is January 17-20, 2014, at the Omni Orlando Resort at ChampionsGate ... The ODAC is a distinguished event that delivers a ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... , MOUNTAIN VIEW, Calif. , Jan. ... of a Phase I clinical trial of CCX168, an ... is a highly potent and very selective compound that ... the body,s complement system and a potent driver of ...
... , EXTON, Pa. , Jan. 28 ... medical technology company that provides innovative solutions and technologies for a ... three and six months ended December 31, 2009 . All ... to those provided in the Company,s January 15, 2010 ...
Cached Medicine Technology:ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases 2ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases 3ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases 4Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 2Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 3Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 4Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 5Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 6Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 7Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 8Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 9Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 10Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 11Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 12Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 13Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 14Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 15Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 16Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 17Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 18Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 19Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results 20
... Aestiva/5 Pendant anesthesia machine offers proven ... range with the SmartVent ventilator. However, ... superior ventilation. Enhancements in flexibility, ergonomics ... in anesthesia delivery., ,The Aestiva/5 ...
With its integrated design and superior build quality each Prima SP is custom built to meet your requirements....
... Tegagel hydrogel wound filler and ... are amorphous hydrogel dressings specially formulated ... that has been shown to enhance ... formula meets clinical needs for management ...
Features various cylinder sizes and a simple two-handed pumping mechanism....
Medicine Products: